Linical Co., Ltd. (2183) Other
Market cap
¥5.1B
P/E ratio
25.7x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 20.9 | 18.8 | 14.8 | 5.1 | 3.5 | 3.7 | 5.1 | 6.1 | 1.9 | -1.3 | -15.6 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 202 | 221 | 296 | 450 | 529 | 599 | 672 | 823 | 842 | 845 | 843 | 759 | 662 | 598 | - |
| Total payout ratio | - | - | - | - | - | 19.9 | 21.6 | 88.8 | - | 58.6 | - | - | - | -62.8 | - |